MIA Co-Medical Director opens SMR Congress in USA
21 November 2019
Professor Georgina Long, Co-Medical Director of Melanoma Institute Australia, has today opened the Society for Melanoma Research 2019 Congress in Salt Lake City, Utah.
Professor Long is the first Australian and the first female President of SMR.
In her opening address, she summed up recent breakthroughs and advances in melanoma research and welcomed delegates from around the globe. This year's SMR Congress will cover a range of melanoma research and treatment related areas including the melanoma microenvironment, advances in early detection and prevention of melanoma, targeted and immunotherapies and advances in acral, mucosal and uveal melanoma. Women in STEM will also be a focus for the Congress.
Professor Long's opening address was followed by a Keynote Presentation on Cellular conversations that control cancer by University of California researcher, Professor Thea Tlsty, and the formal Welcome Reception. SMR continues into the weekend, with a packed program including a number of poster presentations from Melanoma Institute Australia researchers and students.
In sessions prior to the official opening, Co-Medical Director Professor Richard Scolyer led discussions at an International Melanoma Pathology Study Group workshop and the day-long International Melanoma Pathology Symposium.
The opening of SMR comes just a day after Professor Long and Professor Richard Scolyer were recognised as among the world’s most influential in their respective fields by being named in the prestigious Clarivate Analytics 2019 Highly Cited Researchers List.
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina this October, to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.
The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.
We have been buoyed by the wonderful support for our Melanoma March campaign, and our mission to cover Australia in footprints continues into April!
There was a wonderful feeling of community support amongst the melanoma patients, families and friends at the WA Melanoma Community Form.
The Price family has decided to share their story to inspire Australians to support research into new melanoma treatments.
New research has provided evidence in favour of a structured skin surveillance program for high-risk melanoma patients.
Melanoma research saved Bert's life at 101 and now he wants to give back.
A new MIA online risk calculator for clinicians can determine the likelihood of thin melanoma spreading.